Illustrative#ASCO25 Tracker: BioNTech, OSE Tout Positive Data in Difficult Cancers
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
BioNTech and OSE have reported positive data in the treatment of difficult cancers. The data was presented at an event, with both companies touting the results. The specifics of the data and its implications are not detailed in the available information.